GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » GSK PLC (BUE:GSK) » Definitions » Purchase Of Business

GSK (BUE:GSK) Purchase Of Business : ARS-1,439,116 Mil (TTM As of Mar. 2025)


View and export this data going back to . Start your Free Trial

What is GSK Purchase Of Business?

GSK's purchase of business for the three months ended in Mar. 2025 was ARS-1,137,657 Mil. It means GSK spent ARS1,137,657 Mil on purchasing business. GSK's purchase of business for the trailing twelve months (TTM) ended in Mar. 2025 was ARS-1,439,116 Mil.

Compared with last quarter (ARS-125,133 Mil in Dec. 2024 ), GSK spent more money on purchasing business in Mar. 2025 (ARS-1,137,657 Mil).

GSK Purchase Of Business Historical Data

The historical data trend for GSK's Purchase Of Business can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GSK Purchase Of Business Chart

GSK Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Purchase Of Business
Get a 7-Day Free Trial Premium Member Only Premium Member Only -58,519.22 -39,482.79 -688,978.17 -727,026.58 -1,261,542.35

GSK Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Purchase Of Business Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -795,397.08 -82,030.53 -94,295.64 -125,132.74 -1,137,657.04

GSK Purchase Of Business Calculation

The amount used to purchase business.

Purchase Of Business for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ARS-1,439,116 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

GSK Purchase Of Business Related Terms

Thank you for viewing the detailed overview of GSK's Purchase Of Business provided by GuruFocus.com. Please click on the following links to see related term pages.

GSK Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » GSK PLC (BUE:GSK) » Definitions » Purchase Of Business
Comparable Companies
LSE:AZN LLY JNJ ABBV OCSE:NOVO B XSWX:ROG XSWX:NOVN MRK AMGN PFE GILD XPAR:SAN BMY TSE:4519 TSE:4568 SHSE:600276 XTER:BAYN TSE:4578 BIIB TSE:4503
Traded in Other Exchanges
GLAXF:USA GSK:USA GSK1:Mexico GSK N:Mexico GSKl:UK GSK:UK GS71:Germany G1SK34:Brazil
Address
79 New Oxford Street, London, GBR, WC1A 1DG
Website
https://www.gsk.com
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, antiviral, and vaccines, and has been growing its presence in oncology and immunology, as well. GSK uses joint ventures to gain additional scale in certain markets like HIV.